These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 10652043

  • 21. Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism.
    Mauras N, Martinez V, Rini A, Guevara-Aguirre J.
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3036-42. PubMed ID: 10999782
    [Abstract] [Full Text] [Related]

  • 22. Protein and amino acid metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Lindholm B, Bergström J.
    Clin Nephrol; 1988 Sep; 30 Suppl 1():S59-63. PubMed ID: 3141094
    [Abstract] [Full Text] [Related]

  • 23. Short-term effects of recombinant human growth hormone in CAPD patients.
    Ikizler TA, Wingard RL, Breyer JA, Schulman G, Parker RA, Hakim RM.
    Kidney Int; 1994 Oct; 46(4):1178-83. PubMed ID: 7861714
    [Abstract] [Full Text] [Related]

  • 24. The effects of recombinant human insulin-like growth factor-I and growth hormone on body composition in elderly women.
    Thompson JL, Butterfield GE, Marcus R, Hintz RL, Van Loan M, Ghiron L, Hoffman AR.
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1845-52. PubMed ID: 7539817
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patients.
    Fouque D, Peng SC, Kopple JD.
    Kidney Int; 1995 Mar; 47(3):869-75. PubMed ID: 7752586
    [Abstract] [Full Text] [Related]

  • 26. The effect of recombinant human IGF-I on protein metabolism in post-operative patients without nutrition compared to effects in experimental animals.
    Sandström R, Svanberg E, Hyltander A, Haglind E, Ohlsson C, Zachrisson H, Berglund B, Lindholm E, Brevinge H, Lundholm K.
    Eur J Clin Invest; 1995 Oct; 25(10):784-92. PubMed ID: 8557066
    [Abstract] [Full Text] [Related]

  • 27. Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects.
    Mauras N.
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2633-7. PubMed ID: 7673406
    [Abstract] [Full Text] [Related]

  • 28. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
    Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
    [Abstract] [Full Text] [Related]

  • 29. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
    Dong J, Wang H, Wang M.
    J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
    [Abstract] [Full Text] [Related]

  • 30. Peritoneal dialysis with solutions containing amino acids plus glucose promotes protein synthesis during oral feeding.
    Tjiong HL, Rietveld T, Wattimena JL, van den Berg JW, Kahriman D, van der Steen J, Hop WC, Swart R, Fieren MW.
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):74-80. PubMed ID: 17699390
    [Abstract] [Full Text] [Related]

  • 31. Altered physiology and action of insulin-like growth factor 1 in skeletal muscle in chronic renal failure.
    Kopple JD, Ding H, Gao XL.
    Am J Kidney Dis; 1995 Jul; 26(1):248-55. PubMed ID: 7611259
    [Abstract] [Full Text] [Related]

  • 32. Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome.
    Lieberman SA, Butterfield GE, Harrison D, Hoffman AR.
    J Clin Endocrinol Metab; 1994 Feb; 78(2):404-10. PubMed ID: 7508949
    [Abstract] [Full Text] [Related]

  • 33. Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes.
    Clemmons DR, Sleevi M, Allan G, Sommer A.
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2652-8. PubMed ID: 17426090
    [Abstract] [Full Text] [Related]

  • 34. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans.
    Clemmons DR, Smith-Banks A, Underwood LE.
    J Clin Endocrinol Metab; 1992 Jul; 75(1):234-8. PubMed ID: 1619015
    [Abstract] [Full Text] [Related]

  • 35. Six-month overnight administration of intraperitoneal amino acids does not improve lean mass.
    Maurer O, Saxenhofer H, Jaeger P, Casez JP, Descoeudres C, Horber FF.
    Clin Nephrol; 1996 May; 45(5):303-9. PubMed ID: 8738661
    [Abstract] [Full Text] [Related]

  • 36. Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion.
    Woods KA, Camacho-Hübner C, Bergman RN, Barter D, Clark AJ, Savage MO.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1407-11. PubMed ID: 10770174
    [Abstract] [Full Text] [Related]

  • 37. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis.
    Bergström J, Fürst P, Alvestrand A, Lindholm B.
    Kidney Int; 1993 Nov; 44(5):1048-57. PubMed ID: 8264134
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of nutritional status in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Buchwald R, Peña JC.
    Perit Dial Int; 1989 Nov; 9(4):295-301. PubMed ID: 2518698
    [Abstract] [Full Text] [Related]

  • 39. Protein catabolic rate calculations in CAPD patients.
    Keshaviah PR, Nolph KD.
    ASAIO Trans; 1991 Nov; 37(3):M400-2. PubMed ID: 1751208
    [Abstract] [Full Text] [Related]

  • 40. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I.
    Chapman IM, Hartman ML, Pieper KS, Skiles EH, Pezzoli SS, Hintz RL, Thorner MO.
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2836-42. PubMed ID: 9709956
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.